Online weight loss treatment in Pennsylvania
Surfbound connects eligible adults in Pennsylvania with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Pennsylvania?
Yes. Eligible adults across Pennsylvania can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Pennsylvania reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Pennsylvania address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Keystone State · Northeast region. The Philadelphia metro plus rural central and western counties, where obesity-medicine access thins out. Online review bridges the state's geography.
Cities in Pennsylvania
Coverage across Pennsylvania
Surfbound lists 4 Pennsylvania cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Pennsylvania
Every Pennsylvania order is filled by a licensed compounding pharmacy and dispatched after the provider signs off. Addresses across the Northeast region, from Philadelphia, Pittsburgh, Harrisburg to smaller communities see different transit times depending on distance and weekends, and tracking is emailed on dispatch.
What's included in every Pennsylvania plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Pennsylvania coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Pennsylvania. The Pennsylvania provider access & process page covers the clinical steps in detail.
Surfbound lists 4 Pennsylvania cities with a dedicated local page. Because care is delivered online, you can start from anywhere in Pennsylvania — the city list is a navigation aid, not a limit on where you can begin.
The Pennsylvania telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Pennsylvania. You complete a health intake online, and a licensed provider credentialed in Pennsylvania reviews your information remotely.
Pennsylvania permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Pennsylvania may review a Pennsylvania patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Pennsylvania” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Pennsylvania license issued by the Pennsylvania State Board of Medicine, and any pharmacy filling your prescription must be licensed in Pennsylvania. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Pennsylvania” section on this page.
Compounded semaglutide is $169/mo and compounded tirzepatide is $219/mo for Pennsylvania patients, with the provider review included and no separate membership fee. Pricing is shown before checkout, and compounded medications are not FDA-approved.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
Not guaranteed anywhere in Pennsylvania. The Pennsylvania-licensed provider can approve, request more information, or decline after reading your intake.
Switching to Surfbound is possible across Pennsylvania. Enter your current medication and dose in the doctor-notes field; the Pennsylvania-licensed provider decides whether to continue at that dose or adjust it, and no written quote is needed.
Use the GLP-1 total-cost calculator to line up total monthly cost for Pennsylvania residents, including fees other programs add on top, against Surfbound's flat price.
Patients in Pennsylvania can be reviewed for compounded semaglutide. The review, the medication if prescribed, and delivery are covered by one published monthly price. Compounded semaglutide is not FDA-approved.
Yes. Compounded tirzepatide — a dual GIP/GLP-1 receptor agonist — is offered across Pennsylvania at a flat monthly rate with no dose-based upcharge. A Pennsylvania-licensed provider determines whether it is medically appropriate, and the pharmacy ships if prescribed. It is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Pennsylvania residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Pennsylvania-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Pennsylvania. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Pennsylvania provider approves your medication. The Philadelphia metro plus rural central and western counties, where obesity-medicine access thins out.
Yes. Pennsylvania residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Pennsylvania provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Pennsylvania with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Pennsylvania-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. From the Northeast region, Pennsylvania residents can complete the whole process online: a short intake, a remote review by a Pennsylvania-licensed provider, and discreet shipping if treatment is prescribed. Online review bridges the state's geography.
Yes. Men across Pennsylvania begin with a private online intake, a licensed Pennsylvania provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Pennsylvania residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Pennsylvania
What governs a provider treating a Pennsylvania patient online, and where you can check it yourself.
State medical board
Pennsylvania State Board of MedicinePennsylvania State Board of Medicine licenses the providers who review Pennsylvania intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Pennsylvania Medical Practice Act (Act 112 of 2019)Opens the official Pennsylvania code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Pennsylvania license to evaluate or treat a patient who is physically located in Pennsylvania. Every Pennsylvania intake is routed to a provider credentialed in Pennsylvania, and a prescription is issued only when that provider determines treatment is medically appropriate.
Pennsylvania permits telemedicine prescribing when a proper provider-patient relationship exists. The state enacted comprehensive telemedicine legislation in 2019 to support remote care delivery.
Surfbound is an online service. We do not have physical offices in Pennsylvania. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Pennsylvania and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Pennsylvania state government agency. Provider licensure in Pennsylvania is governed by the Pennsylvania State Board of Medicine.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.